Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. more
Time Frame | IMRN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -3.88% | 1.76% | -2.5% |
1-Month Return | -7.31% | 0.33% | -3.91% |
3-Month Return | -11.26% | -8.58% | -0.59% |
6-Month Return | -18.76% | -4.26% | 3.45% |
1-Year Return | 3.96% | 1.27% | 22.31% |
3-Year Return | -44.03% | 5.33% | 25% |
5-Year Return | -46.76% | 38.09% | 77.23% |
10-Year Return | -53.6% | 102.29% | 188.04% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 2.52M | 145.78K | 765.19K | 1.80M | 4.90M | [{"date":"2020-06-30","value":51.37,"profit":true},{"date":"2021-06-30","value":2.97,"profit":true},{"date":"2022-06-30","value":15.61,"profit":true},{"date":"2023-06-30","value":36.81,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Cost of Revenue | 688.84K | 51.07K | 241.69K | 495.56K | 1.57M | [{"date":"2020-06-30","value":43.99,"profit":true},{"date":"2021-06-30","value":3.26,"profit":true},{"date":"2022-06-30","value":15.43,"profit":true},{"date":"2023-06-30","value":31.64,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Gross Profit | 1.83M | 94.70K | 523.50K | 1.31M | 3.34M | [{"date":"2020-06-30","value":54.83,"profit":true},{"date":"2021-06-30","value":2.84,"profit":true},{"date":"2022-06-30","value":15.69,"profit":true},{"date":"2023-06-30","value":39.23,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Gross Margin | 72.65% | 64.97% | 68.41% | 72.54% | 68.06% | [{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":89.42,"profit":true},{"date":"2022-06-30","value":94.17,"profit":true},{"date":"2023-06-30","value":99.85,"profit":true},{"date":"2024-06-30","value":93.68,"profit":true}] |
Operating Expenses | 4.75M | 7.29M | 3.64M | 4.72M | 9.14M | [{"date":"2020-06-30","value":51.94,"profit":true},{"date":"2021-06-30","value":79.76,"profit":true},{"date":"2022-06-30","value":39.84,"profit":true},{"date":"2023-06-30","value":51.61,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Operating Income | (2.92M) | (7.19M) | (3.12M) | (3.57M) | (5.80M) | [{"date":"2020-06-30","value":-291691000,"profit":false},{"date":"2021-06-30","value":-719374300,"profit":false},{"date":"2022-06-30","value":-311741300,"profit":false},{"date":"2023-06-30","value":-356883800,"profit":false},{"date":"2024-06-30","value":-580111800,"profit":false}] |
Total Non-Operating Income/Expense | (31.93K) | (430.04K) | 117.16K | (111.00K) | (815.66K) | [{"date":"2020-06-30","value":-27.25,"profit":false},{"date":"2021-06-30","value":-367.06,"profit":false},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":-94.74,"profit":false},{"date":"2024-06-30","value":-696.19,"profit":false}] |
Pre-Tax Income | (2.93M) | (8.38M) | (2.85M) | (3.79M) | (6.94M) | [{"date":"2020-06-30","value":-292720600,"profit":false},{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}] |
Income Taxes | (22.43K) | 13.76K | (263.16K) | (314.69K) | (764.98K) | [{"date":"2020-06-30","value":-162.96,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-1912.35,"profit":false},{"date":"2023-06-30","value":-2286.81,"profit":false},{"date":"2024-06-30","value":-5559.05,"profit":false}] |
Income After Taxes | (2.90M) | (8.40M) | (2.59M) | (3.47M) | (6.17M) | [{"date":"2020-06-30","value":-290478100,"profit":false},{"date":"2021-06-30","value":-839822600,"profit":false},{"date":"2022-06-30","value":-259109500,"profit":false},{"date":"2023-06-30","value":-347181900,"profit":false},{"date":"2024-06-30","value":-617197600,"profit":false}] |
Income From Continuous Operations | (2.93M) | (8.38M) | (2.85M) | (3.79M) | (6.94M) | [{"date":"2020-06-30","value":-292720600,"profit":false},{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (2.90M) | (8.40M) | (2.59M) | (3.79M) | (6.94M) | [{"date":"2020-06-30","value":-290478100,"profit":false},{"date":"2021-06-30","value":-839822600,"profit":false},{"date":"2022-06-30","value":-259109500,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}] |
EPS (Diluted) | (0.02) | (0.02) | - | - | - | [{"date":"2020-06-30","value":-1.75,"profit":false},{"date":"2021-06-30","value":-1.9,"profit":false},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
IMRN | |
---|---|
Cash Ratio | 4.32 |
Current Ratio | 5.46 |
Quick Ratio | 4.87 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IMRN | |
---|---|
ROA (LTM) | -17.37% |
ROE (LTM) | -42.92% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IMRN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.18 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.82 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IMRN | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.36 |
P/B | 1.41 |
Price/FCF | NM |
EV/R | 1.47 |
EV/Ebitda | 0.77 |
PEG | NM |
Immuron Ltd ADR (IMRN) share price today is $1.97
Yes, Indians can buy shares of Immuron Ltd ADR (IMRN) on Vested. To buy Immuron Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMRN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Immuron Ltd ADR (IMRN) via the Vested app. You can start investing in Immuron Ltd ADR (IMRN) with a minimum investment of $1.
You can invest in shares of Immuron Ltd ADR (IMRN) via Vested in three simple steps:
The 52-week high price of Immuron Ltd ADR (IMRN) is $5.96. The 52-week low price of Immuron Ltd ADR (IMRN) is $1.59.
The price-to-earnings (P/E) ratio of Immuron Ltd ADR (IMRN) is
The price-to-book (P/B) ratio of Immuron Ltd ADR (IMRN) is 1.41
The dividend yield of Immuron Ltd ADR (IMRN) is 0.00%
The market capitalization of Immuron Ltd ADR (IMRN) is $11.17M
The stock symbol (or ticker) of Immuron Ltd ADR is IMRN